Koers Pressure BioSciences, Inc. Other OTC
Aandelen
PBIO
US74112E2081
Medische apparatuur, benodigdheden & distributie
Omzet 2021 | 2 mln. 1,85 mln. | Omzet 2022 | 1,73 mln. 1,59 mln. | Marktkapitalisatie | 15,89 mln. 14,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -20 mln. -18,43 mln. | Nettowinst (verlies) 2022 | -16 mln. -14,74 mln. | EV/omzet 2021 | 16,4 x |
Nettoschuld 2021 | 14,51 mln. 13,37 mln. | Nettoschuld 2022 | 20,53 mln. 18,91 mln. | EV/omzet 2022 | 21,1 x |
K/w-verhouding 2021 |
-0,68
x | K/w-verhouding 2022 |
-0,81
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 98,82% |
Recentste transcriptie over Pressure BioSciences, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 73 | 01-08-78 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 24-04-06 |
Chief Tech/Sci/R&D Officer | 59 | 03-04-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 73 | 01-08-78 | |
Vito Mangiardi
BRD | Director/Board Member | 75 | 03-07-12 |
Michael Urdea
BRD | Director/Board Member | 71 | 08-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-7,38% | 181 mld. | |
-0,46% | 108 mld. | |
-6,98% | 66,12 mld. | |
+2,65% | 50,65 mld. | |
+5,27% | 43,11 mld. | |
+3,49% | 40,74 mld. | |
+19,92% | 31,6 mld. | |
+16,38% | 25,56 mld. | |
-7,00% | 24,16 mld. |